GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Entrada Therapeutics rises 11.94% in Tuesday's session

Published by Global Banking & Finance Review

Posted on November 10, 2026

1 min read
Add as preferred source on Google
TRDA 5.25 +11.94% last traded price, 10 Nov 2026
Previous close
4.69
Market cap
—

The figures in this article were checked against this snapshot before publication.

Entrada Therapeutics shares last traded 11.94% higher than their previous close, reaching 5.25 USD on 10 November 2026. The previous close was 4.69 USD. The move occurred in the United States health care market.

Last traded price5.25 USD
Previous close4.69 USD
Change from the previous close+11.94%

Prices of Entrada Therapeutics (TRDA), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 10 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 9 November 2026. We report a stock the day it ends a session 2% or more away from its previous close, where at least 100,000 shares or US$5 million traded in the previous session. How we compile these reports.

Entrada Therapeutics — daily TRDA Delayed

Related Articles

More from Markets

Explore more articles in the Markets category